Bifidobacterium Infantis is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
The global Bifidobacterium Infantis market size is projected to grow from US$ 43.7 million in 2024 to US$ 63.6 million in 2030; it is expected to grow at a CAGR of 6.4% from 2024 to 2030.
The 鈥淏ifidobacterium Infantis Industry Forecast鈥� looks at past sales and reviews total world Bifidobacterium Infantis sales in 2023, providing a comprehensive analysis by region and market sector of projected Bifidobacterium Infantis sales for 2024 through 2030. With Bifidobacterium Infantis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bifidobacterium Infantis industry.
This Insight Report provides a comprehensive analysis of the global Bifidobacterium Infantis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bifidobacterium Infantis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bifidobacterium Infantis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bifidobacterium Infantis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bifidobacterium Infantis.
United States market for Bifidobacterium Infantis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Bifidobacterium Infantis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Bifidobacterium Infantis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Bifidobacterium Infantis players cover Mitushi Biopharma, Fengchen Group, Jiangsu Wecare Biotechnology Co., Ltd., Shenzhen Lefu Biotechnology Co., Ltd., Hebei Hongtao Bioengineering Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Bifidobacterium Infantis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
0-50 billion CFU/g
50-100 billion CFU/g
锛�100 billion CFU/g
Segmentation by Application:
Food Additives
Medicines and Supplements
Feed Additives
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mitushi Biopharma
Fengchen Group
Jiangsu Wecare Biotechnology Co., Ltd.
Shenzhen Lefu Biotechnology Co., Ltd.
Hebei Hongtao Bioengineering Co., Ltd.
Shandong Junle Biotechnology Co., Ltd.
Shandong Xinxiong Biotechnology Co., Ltd.
Newgen Biotech
Pharm-Rx
Rajvi Enterprise
Shandong Pingao Pharmaceutical Co., Ltd.
Shaanxi Chenming Biotechnology Co., Ltd.
Xi'an Minglang Biotechnology Co., Ltd.
Jiahe Biotechnology (Shanxi) Co., Ltd.
Shaanxi Ruimao Biotechnology Co., Ltd.
Shaanxi Baohe Biotechnology Co., Ltd.
Shaanxi Lesent Biotechnology Co., Ltd.
Shaanxi Shuoyang Biotechnology Co., Ltd.
Shaanxi Mufan Biotechnology Co., Ltd.
Xi'an An'Drong Biomedical Technology Co., Ltd.
Shaanxi Guanchen Biotechnology Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bifidobacterium Infantis market?
What factors are driving Bifidobacterium Infantis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bifidobacterium Infantis market opportunities vary by end market size?
How does Bifidobacterium Infantis break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bifidobacterium Infantis Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Bifidobacterium Infantis by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Bifidobacterium Infantis by Country/Region, 2019, 2023 & 2030
2.2 Bifidobacterium Infantis Segment by Type
2.2.1 0-50 billion CFU/g
2.2.2 50-100 billion CFU/g
2.2.3 锛�100 billion CFU/g
2.3 Bifidobacterium Infantis Sales by Type
2.3.1 Global Bifidobacterium Infantis Sales Market Share by Type (2019-2024)
2.3.2 Global Bifidobacterium Infantis Revenue and Market Share by Type (2019-2024)
2.3.3 Global Bifidobacterium Infantis Sale Price by Type (2019-2024)
2.4 Bifidobacterium Infantis Segment by Application
2.4.1 Food Additives
2.4.2 Medicines and Supplements
2.4.3 Feed Additives
2.4.4 Others
2.5 Bifidobacterium Infantis Sales by Application
2.5.1 Global Bifidobacterium Infantis Sale Market Share by Application (2019-2024)
2.5.2 Global Bifidobacterium Infantis Revenue and Market Share by Application (2019-2024)
2.5.3 Global Bifidobacterium Infantis Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Bifidobacterium Infantis Breakdown Data by Company
3.1.1 Global Bifidobacterium Infantis Annual Sales by Company (2019-2024)
3.1.2 Global Bifidobacterium Infantis Sales Market Share by Company (2019-2024)
3.2 Global Bifidobacterium Infantis Annual Revenue by Company (2019-2024)
3.2.1 Global Bifidobacterium Infantis Revenue by Company (2019-2024)
3.2.2 Global Bifidobacterium Infantis Revenue Market Share by Company (2019-2024)
3.3 Global Bifidobacterium Infantis Sale Price by Company
3.4 Key Manufacturers Bifidobacterium Infantis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bifidobacterium Infantis Product Location Distribution
3.4.2 Players Bifidobacterium Infantis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bifidobacterium Infantis by Geographic Region
4.1 World Historic Bifidobacterium Infantis Market Size by Geographic Region (2019-2024)
4.1.1 Global Bifidobacterium Infantis Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Bifidobacterium Infantis Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Bifidobacterium Infantis Market Size by Country/Region (2019-2024)
4.2.1 Global Bifidobacterium Infantis Annual Sales by Country/Region (2019-2024)
4.2.2 Global Bifidobacterium Infantis Annual Revenue by Country/Region (2019-2024)
4.3 Americas Bifidobacterium Infantis Sales Growth
4.4 APAC Bifidobacterium Infantis Sales Growth
4.5 Europe Bifidobacterium Infantis Sales Growth
4.6 Middle East & Africa Bifidobacterium Infantis Sales Growth
5 Americas
5.1 Americas Bifidobacterium Infantis Sales by Country
5.1.1 Americas Bifidobacterium Infantis Sales by Country (2019-2024)
5.1.2 Americas Bifidobacterium Infantis Revenue by Country (2019-2024)
5.2 Americas Bifidobacterium Infantis Sales by Type (2019-2024)
5.3 Americas Bifidobacterium Infantis Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bifidobacterium Infantis Sales by Region
6.1.1 APAC Bifidobacterium Infantis Sales by Region (2019-2024)
6.1.2 APAC Bifidobacterium Infantis Revenue by Region (2019-2024)
6.2 APAC Bifidobacterium Infantis Sales by Type (2019-2024)
6.3 APAC Bifidobacterium Infantis Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bifidobacterium Infantis by Country
7.1.1 Europe Bifidobacterium Infantis Sales by Country (2019-2024)
7.1.2 Europe Bifidobacterium Infantis Revenue by Country (2019-2024)
7.2 Europe Bifidobacterium Infantis Sales by Type (2019-2024)
7.3 Europe Bifidobacterium Infantis Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bifidobacterium Infantis by Country
8.1.1 Middle East & Africa Bifidobacterium Infantis Sales by Country (2019-2024)
8.1.2 Middle East & Africa Bifidobacterium Infantis Revenue by Country (2019-2024)
8.2 Middle East & Africa Bifidobacterium Infantis Sales by Type (2019-2024)
8.3 Middle East & Africa Bifidobacterium Infantis Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidobacterium Infantis
10.3 Manufacturing Process Analysis of Bifidobacterium Infantis
10.4 Industry Chain Structure of Bifidobacterium Infantis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bifidobacterium Infantis Distributors
11.3 Bifidobacterium Infantis Customer
12 World Forecast Review for Bifidobacterium Infantis by Geographic Region
12.1 Global Bifidobacterium Infantis Market Size Forecast by Region
12.1.1 Global Bifidobacterium Infantis Forecast by Region (2025-2030)
12.1.2 Global Bifidobacterium Infantis Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Bifidobacterium Infantis Forecast by Type (2025-2030)
12.7 Global Bifidobacterium Infantis Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Mitushi Biopharma
13.1.1 Mitushi Biopharma Company Information
13.1.2 Mitushi Biopharma Bifidobacterium Infantis Product Portfolios and Specifications
13.1.3 Mitushi Biopharma Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Mitushi Biopharma Main Business Overview
13.1.5 Mitushi Biopharma Latest Developments
13.2 Fengchen Group
13.2.1 Fengchen Group Company Information
13.2.2 Fengchen Group Bifidobacterium Infantis Product Portfolios and Specifications
13.2.3 Fengchen Group Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Fengchen Group Main Business Overview
13.2.5 Fengchen Group Latest Developments
13.3 Jiangsu Wecare Biotechnology Co., Ltd.
13.3.1 Jiangsu Wecare Biotechnology Co., Ltd. Company Information
13.3.2 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.3.3 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jiangsu Wecare Biotechnology Co., Ltd. Main Business Overview
13.3.5 Jiangsu Wecare Biotechnology Co., Ltd. Latest Developments
13.4 Shenzhen Lefu Biotechnology Co., Ltd.
13.4.1 Shenzhen Lefu Biotechnology Co., Ltd. Company Information
13.4.2 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.4.3 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Shenzhen Lefu Biotechnology Co., Ltd. Main Business Overview
13.4.5 Shenzhen Lefu Biotechnology Co., Ltd. Latest Developments
13.5 Hebei Hongtao Bioengineering Co., Ltd.
13.5.1 Hebei Hongtao Bioengineering Co., Ltd. Company Information
13.5.2 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.5.3 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Hebei Hongtao Bioengineering Co., Ltd. Main Business Overview
13.5.5 Hebei Hongtao Bioengineering Co., Ltd. Latest Developments
13.6 Shandong Junle Biotechnology Co., Ltd.
13.6.1 Shandong Junle Biotechnology Co., Ltd. Company Information
13.6.2 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.6.3 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shandong Junle Biotechnology Co., Ltd. Main Business Overview
13.6.5 Shandong Junle Biotechnology Co., Ltd. Latest Developments
13.7 Shandong Xinxiong Biotechnology Co., Ltd.
13.7.1 Shandong Xinxiong Biotechnology Co., Ltd. Company Information
13.7.2 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.7.3 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shandong Xinxiong Biotechnology Co., Ltd. Main Business Overview
13.7.5 Shandong Xinxiong Biotechnology Co., Ltd. Latest Developments
13.8 Newgen Biotech
13.8.1 Newgen Biotech Company Information
13.8.2 Newgen Biotech Bifidobacterium Infantis Product Portfolios and Specifications
13.8.3 Newgen Biotech Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Newgen Biotech Main Business Overview
13.8.5 Newgen Biotech Latest Developments
13.9 Pharm-Rx
13.9.1 Pharm-Rx Company Information
13.9.2 Pharm-Rx Bifidobacterium Infantis Product Portfolios and Specifications
13.9.3 Pharm-Rx Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Pharm-Rx Main Business Overview
13.9.5 Pharm-Rx Latest Developments
13.10 Rajvi Enterprise
13.10.1 Rajvi Enterprise Company Information
13.10.2 Rajvi Enterprise Bifidobacterium Infantis Product Portfolios and Specifications
13.10.3 Rajvi Enterprise Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Rajvi Enterprise Main Business Overview
13.10.5 Rajvi Enterprise Latest Developments
13.11 Shandong Pingao Pharmaceutical Co., Ltd.
13.11.1 Shandong Pingao Pharmaceutical Co., Ltd. Company Information
13.11.2 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.11.3 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shandong Pingao Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Shandong Pingao Pharmaceutical Co., Ltd. Latest Developments
13.12 Shaanxi Chenming Biotechnology Co., Ltd.
13.12.1 Shaanxi Chenming Biotechnology Co., Ltd. Company Information
13.12.2 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.12.3 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shaanxi Chenming Biotechnology Co., Ltd. Main Business Overview
13.12.5 Shaanxi Chenming Biotechnology Co., Ltd. Latest Developments
13.13 Xi'an Minglang Biotechnology Co., Ltd.
13.13.1 Xi'an Minglang Biotechnology Co., Ltd. Company Information
13.13.2 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.13.3 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Xi'an Minglang Biotechnology Co., Ltd. Main Business Overview
13.13.5 Xi'an Minglang Biotechnology Co., Ltd. Latest Developments
13.14 Jiahe Biotechnology (Shanxi) Co., Ltd.
13.14.1 Jiahe Biotechnology (Shanxi) Co., Ltd. Company Information
13.14.2 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.14.3 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Jiahe Biotechnology (Shanxi) Co., Ltd. Main Business Overview
13.14.5 Jiahe Biotechnology (Shanxi) Co., Ltd. Latest Developments
13.15 Shaanxi Ruimao Biotechnology Co., Ltd.
13.15.1 Shaanxi Ruimao Biotechnology Co., Ltd. Company Information
13.15.2 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.15.3 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Shaanxi Ruimao Biotechnology Co., Ltd. Main Business Overview
13.15.5 Shaanxi Ruimao Biotechnology Co., Ltd. Latest Developments
13.16 Shaanxi Baohe Biotechnology Co., Ltd.
13.16.1 Shaanxi Baohe Biotechnology Co., Ltd. Company Information
13.16.2 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.16.3 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shaanxi Baohe Biotechnology Co., Ltd. Main Business Overview
13.16.5 Shaanxi Baohe Biotechnology Co., Ltd. Latest Developments
13.17 Shaanxi Lesent Biotechnology Co., Ltd.
13.17.1 Shaanxi Lesent Biotechnology Co., Ltd. Company Information
13.17.2 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.17.3 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Shaanxi Lesent Biotechnology Co., Ltd. Main Business Overview
13.17.5 Shaanxi Lesent Biotechnology Co., Ltd. Latest Developments
13.18 Shaanxi Shuoyang Biotechnology Co., Ltd.
13.18.1 Shaanxi Shuoyang Biotechnology Co., Ltd. Company Information
13.18.2 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.18.3 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Shaanxi Shuoyang Biotechnology Co., Ltd. Main Business Overview
13.18.5 Shaanxi Shuoyang Biotechnology Co., Ltd. Latest Developments
13.19 Shaanxi Mufan Biotechnology Co., Ltd.
13.19.1 Shaanxi Mufan Biotechnology Co., Ltd. Company Information
13.19.2 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.19.3 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Shaanxi Mufan Biotechnology Co., Ltd. Main Business Overview
13.19.5 Shaanxi Mufan Biotechnology Co., Ltd. Latest Developments
13.20 Xi'an An'Drong Biomedical Technology Co., Ltd.
13.20.1 Xi'an An'Drong Biomedical Technology Co., Ltd. Company Information
13.20.2 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.20.3 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Xi'an An'Drong Biomedical Technology Co., Ltd. Main Business Overview
13.20.5 Xi'an An'Drong Biomedical Technology Co., Ltd. Latest Developments
13.21 Shaanxi Guanchen Biotechnology Co., Ltd.
13.21.1 Shaanxi Guanchen Biotechnology Co., Ltd. Company Information
13.21.2 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Infantis Product Portfolios and Specifications
13.21.3 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Infantis Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Shaanxi Guanchen Biotechnology Co., Ltd. Main Business Overview
13.21.5 Shaanxi Guanchen Biotechnology Co., Ltd. Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
